In addition to TERT, we found rare non-synonymous variants in three genes associated with decreased prostate cancer risk (ANO7, SPDL1 and AR), and three genes associated with increased risk (HOXB13, CHEK2 and BIK). Here, CHEK2 is linked to prostate carcinoma.